Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17250
Corporate User License Price USD 750
Corporate User License Price INR 51750
Site License Price USD 500
Site License Price INR 34500
Request a Quote

Report Title

AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile



Executive Summary

Summary

AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases. It is also developing new approaches to the treatment of asthma. The company's product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies, distributors and local representative offices. The company markets its products to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in Cambridge, Cambridgeshire, the UK.

AstraZeneca Plc (AZN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 6

List of Figures 7

AstraZeneca Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

AstraZeneca Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 9

AstraZeneca Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

AstraZeneca Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 11

AstraZeneca Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

AstraZeneca Plc, Medical Equipment, Deal Details 15

Venture Financing 15

Rani Therapeutics Raises Funds in Financing 15

Definiens Raises USD20.3 Million in Venture Financing Round 17

CeraPedics Raises USD 19 Million In Series C Financing 18

Definiens Raises USD 13 Million In Venture Financing 19

Partnerships 20

AstraZeneca Enters into Licensing Agreement with Pelago Bioscience 20

AstraZeneca Enters into Agreement with Genedata 21

Definiens Enters into Co-Development Agreement with Merck 22

Emulate Enters into Partnership Agreement with AstraZeneca 23

Procella Therapeutics and Smartwise Enter into Development Agreement with AstraZeneca 24

Chembio Diagnostic Enters into Agreement with AstraZeneca 25

Trovagene Enters into Agreement with AstraZeneca 26

AstraZeneca Enters into Partnership with DNAnexus 27

NeoGenomics and Definiens Enter into Agreement 28

SenzaGen Enters into Agreement with AstraZeneca 29

Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 30

AgPlus Diagnostics Enters into Agreement with AstraZeneca 31

Indivumed Partners with Definiens 32

Foundation Medicine Enters into Agreement with AstraZeneca 33

Definiens Partners with MolecularMD 34

MedImmune Enters into Agreement with Genisphere 35

Human Longevity Partners with AstraZeneca 36

PROOF Centre Partners with AstraZeneca 37

Cepheid, MedImmune and Combacte Enter into Agreement 38

Labcyte Enters into Agreement with AstraZeneca 39

HighRes Biosolutions Enters into Agreement with AstraZeneca 40

AstraZeneca Enters into Research Agreement with Sutter Health 41

Myriad Genetics Expands Agreement with AstraZeneca 42

Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 43

AstraZeneca Enters into Co-Development Agreement with Qiagen 44

AstraZeneca Enters into Co-Development Agreement with Roche 45

Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 46

Ventana Medical Enters into Co-Development Agreement with MedImmune 47

Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 48

Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 49

Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery 50

AstraZeneca Enters Into Research Agreement With Karolinska Institutet 51

Merger 52

AstraZeneca Rumored To Merge With Amgen 52

Equity Offering 53

OnDosis Spins Out from AstraZeneca 53

Debt Offering 54

AstraZeneca Prices Public Offering of 3.5% Notes due 2023 for USD0.85 Billion 54

AstraZeneca Prices Public Offering of 4% Notes due 2029 for USD1 Billion 56

AstraZeneca Prices Public Offering of 4.375% Notes due 2048 for USD0.75 Billion 58

AstraZeneca Prices Public Offering of Floating Rate Notes due 2023 for USD0.4 Billion 60

AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 62

Acquisition 63

AstraZeneca to Acquire Additional 5.7% Stake in Circassia Pharma 63

Pfizer May Increase Bid to Acquire AstraZeneca 64

MedImmune Acquires Definiens for USD150 Million 66

Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company 67

AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 69

AstraZeneca Plc-Key Competitors 70

AstraZeneca Plc-Key Employees 71

AstraZeneca Plc-Locations And Subsidiaries 74

Head Office 74

Other Locations & Subsidiaries 74

Joint Venture 80

Recent Developments 81

Strategy And Business Planning 81

Oct 01, 2017: Molnlycke to establish R&D innovation unit in AstraZeneca's BioVentureHub 81

Apr 25, 2017: AstraZeneca marks a key milestone with the 'topping out' of new global R&D centre and HQ in Cambridge, UK 82

Financial Announcements 84

Jul 26, 2018: AstraZeneca announces H1 2018 results 84

May 18, 2018: AstraZeneca: Q1 2018 Results 98

Feb 02, 2018: AstraZeneca: Full-Year 2017 Results 100

Nov 09, 2017: AstraZeneca Announces Year-To-Date and Q3 2017 Results 102

Jul 27, 2017: AstraZeneca Announce H1 2017 Results 110

Apr 27, 2017: AstraZeneca Announces Q1 2017 Results 120

Feb 02, 2017: Astrazeneca Announces Full-Year and Q4 2016 Results 121

Corporate Communications 122

Sep 06, 2018: AstraZeneca: Directorate change 122

Jun 26, 2018: AstraZeneca Announces Board Committee Changes 123

Apr 05, 2018: AstraZeneca: Non-Executive Directors' Retirement Plans 124

Dec 01, 2017: Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer 125

Sep 05, 2017: Astrazeneca Appoints Sheri Mccoy and Deborah Disanzo to its Board 126

Aug 16, 2017: Astrazeneca Non-executive Director Retirement 128

Jul 31, 2017: AstraZeneca and MedImmune strengthen immuno-oncology leadership with appointment of two renowned experts31 July 2017 129

Jun 29, 2017: Astra Zeneca: Outcome of the meeting of board of directors held on June 29, 2017 130

May 31, 2017: AstraZeneca appoints Professor Nazneen Rahman to its Board of Directors and Science Committee 131

Mar 06, 2017: Changes to AstraZeneca Board of Directors 132

Legal and Regulatory 133

Aug 01, 2018: AstraZeneca faces US DOJ probe for alleged funding of Iraqi terrorists 133

Product News 134

Jul 09, 2018: Microsoft and Partners Showcase a New 'Molecule' for Better Health Outcomes 134

Other Significant Developments 135

Jul 10, 2018: Revon Systems' Digital Therapeutics Enters Collaboration with AstraZeneca in Respiratory Medicine 135

Jan 25, 2018: ACT Genomics collaborates with AstraZeneca on BRCA testing 136

Nov 01, 2017: CN Bio Innovations announces research collaboration with AstraZeneca to validate a new in vitro tool to predict optimised drug dosing regimens for multi-drug therapies 137

Sep 27, 2017: Inhalation Sciences gets large order from AstraZeneca 138

Jun 06, 2017: AstraZeneca Selects ArisGlobal LifeSphere Safety-Risk Management 139

Mar 31, 2017: First Collaborative Definition of Patient Centricity, Co-created by AstraZeneca with Patients and Carers, Is Published in British Medical Journal 140

Appendix 141

Methodology 141

About GlobalData 141

Contact Us 141

Disclaimer 141

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

AstraZeneca Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

AstraZeneca Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

AstraZeneca Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

AstraZeneca Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

AstraZeneca Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

AstraZeneca Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 9

AstraZeneca Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

AstraZeneca Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

List of Tables

AstraZeneca Plc, Medical Equipment, Key Facts, 2017 2

AstraZeneca Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

AstraZeneca Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

AstraZeneca Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 9

AstraZeneca Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

AstraZeneca Plc, Deals By Market, 2012 to YTD 2018 11

AstraZeneca Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

Rani Therapeutics Raises Funds in Financing 15

Definiens Raises USD20.3 Million in Venture Financing Round 17

CeraPedics Raises USD 19 Million In Series C Financing 18

Definiens Raises USD 13 Million In Venture Financing 19

AstraZeneca Enters into Licensing Agreement with Pelago Bioscience 20

AstraZeneca Enters into Agreement with Genedata 21

Definiens Enters into Co-Development Agreement with Merck 22

Emulate Enters into Partnership Agreement with AstraZeneca 23

Procella Therapeutics and Smartwise Enter into Development Agreement with AstraZeneca 24

Chembio Diagnostic Enters into Agreement with AstraZeneca 25

Trovagene Enters into Agreement with AstraZeneca 26

AstraZeneca Enters into Partnership with DNAnexus 27

NeoGenomics and Definiens Enter into Agreement 28

SenzaGen Enters into Agreement with AstraZeneca 29

Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 30

AgPlus Diagnostics Enters into Agreement with AstraZeneca 31

Indivumed Partners with Definiens 32

Foundation Medicine Enters into Agreement with AstraZeneca 33

Definiens Partners with MolecularMD 34

MedImmune Enters into Agreement with Genisphere 35

Human Longevity Partners with AstraZeneca 36

PROOF Centre Partners with AstraZeneca 37

Cepheid, MedImmune and Combacte Enter into Agreement 38

Labcyte Enters into Agreement with AstraZeneca 39

HighRes Biosolutions Enters into Agreement with AstraZeneca 40

AstraZeneca Enters into Research Agreement with Sutter Health 41

Myriad Genetics Expands Agreement with AstraZeneca 42

Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 43

AstraZeneca Enters into Co-Development Agreement with Qiagen 44

AstraZeneca Enters into Co-Development Agreement with Roche 45

Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 46

Ventana Medical Enters into Co-Development Agreement with MedImmune 47

Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 48

Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 49

Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery 50

AstraZeneca Enters Into Research Agreement With Karolinska Institutet 51

AstraZeneca Rumored To Merge With Amgen 52

OnDosis Spins Out from AstraZeneca 53

AstraZeneca Prices Public Offering of 3.5% Notes due 2023 for USD0.85 Billion 54

AstraZeneca Prices Public Offering of 4% Notes due 2029 for USD1 Billion 56

AstraZeneca Prices Public Offering of 4.375% Notes due 2048 for USD0.75 Billion 58

AstraZeneca Prices Public Offering of Floating Rate Notes due 2023 for USD0.4 Billion 60

AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 62

AstraZeneca to Acquire Additional 5.7% Stake in Circassia Pharma 63

Pfizer May Increase Bid to Acquire AstraZeneca 64

MedImmune Acquires Definiens for USD150 Million 66

Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company 67

AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 69

AstraZeneca Plc, Key Competitors 70

AstraZeneca Plc, Key Employees 71

AstraZeneca Plc, Subsidiaries 74

AstraZeneca Plc, Joint Venture 80

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

AstraZeneca Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person